1. Sequential Doxorubicin and Docetaxel as First-Line Treatment in Metastatic Breast Cancer: A GEICAM-9801 Phase II Study

   • E. Alba
   • N. Ribelles
   • M.J. Godes

   OriginalPaper Pages: 1 - 8

2. Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy^*

   • Daniel Albo
   • Frederick C. Ames
   • Henry M. Kuerer

   OriginalPaper Pages: 9 - 14

3. The Expression of Growth Hormone-Releasing Hormone (GHRH) and its Receptor Splice Variants in Human Breast Cancer Lines; The Evaluation of Signaling Mechanisms in the Stimulation of Cell Proliferation

   • M. Olga Garcia-Fernandez
   • Andrew V. Schally
   • Rebeca Busto

   OriginalPaper Pages: 15 - 26

4. Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density

   • Christopher A. Haiman
   • Susan E. Hankinson
   • Celia Byrne

   OriginalPaper Pages: 27 - 36

5. Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History

   • F. Feuerhake
   • W. Sigg
   • U. Welsch

   OriginalPaper Pages: 37 - 48

6. Sex Hormone-Induced Mammary Carcinogenesis in Female Noble Rats: Detection of Differentially Expressed Genes

   • G. Leung
   • S.W. Tsao
   • Y.C. Wong

   OriginalPaper Pages: 49 - 63

7. Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model

   • Ryan G. Holzer
   • Christina MacDougall
   • Cheryl L. Jorcyk

   OriginalPaper Pages: 65 - 76

8. The Prognostic Value of the Mitotic Activity Index in Patients with Primary Breast Cancer Who were not Treated with Adjuvant Systemic Therapy

   • P. Manders
   • P. Bult
   • L.V.A.M. Beex

   OriginalPaper Pages: 77 - 84

9. Matrix Metalloproteinase-2 (MMP-2) in T_1–2N₀ breast carcinoma

   • Riikka Hirvonen
   • Anne Talvensaari-Mattila
   • Taina Turpeenniemi-Hujanen

   OriginalPaper Pages: 85 - 91